(Q33924908)
Statements
Erlotinib, erlotinib-sulindac versus placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck cancer (English)
Jennifer R Grandis
Jonas T Johnson
Neil D Gross
Julie E Bauman
William E Gooding
William Denq
Lin Wang
Brian L Hood
Mai Sun
Thomas P Conrads
Seungwon Kim
Athanassios Argiris
Lori Wirth
Marina N Nikiforova
Jill M Siegfried
1 reference
1 reference